B-cell lymphopenia is common among HD patients and is due to an increased apoptosis mediated by a decreased Bcl-2 expression and a resistance to IL-7 and B-cell-activating factor of the TNF family, both necessary for the differentiation and survival of B-cells (12, 42). The gene discussed is BCL2; the disease is Huntington disease.